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BRIEF COMMUNICATION
Infective Endocarditis Hospitalizations and 
Outcomes in Patients With End- Stage 
Kidney Disease: A Nationwide Data- Linkage 
Study
Peter J. Gallacher , MD, MPH; David A. McAllister, MD, PhD; Nicholas L. Mills , MD, PhD;  
Nicholas L. Cruden, MD, PhD; Anoop S. V. Shah , MD, PhD; Neeraj Dhaun , MD, PhD
BACKGROUND: We investigated the clinical features, microbiology, and short- and long- term outcomes of incident infective 
endocarditis (IE) hospitalizations in patients with end- stage kidney disease (ESKD) requiring dialysis or with a kidney trans-
plant over 25 years in Scotland.
METHODS AND RESULTS: In this retrospective, population- based cohort study linking national hospitalization and mortality data, 
we identified patients with a history of ESKD and hospitalized with IE in Scotland between January 1, 1990 and December 31, 
2014. From January 1, 2008, individual IE hospitalizations were additionally linked to national microbiology data. Multivariable 
logistic regression, adjusting for patient demographics and comorbidities, evaluated the association between ESKD and all- 
cause death at 1 and 3 years. Of 7638 incident IE hospitalizations between 1990 and 2014, 2.8% (216/7638) occurred in 210 
patients with ESKD and 97.2% (7422/7638) occurred in 7303 patients without ESKD. Positive findings from blood cultures 
were identified in 42% (950/2267) of incident IE hospitalizations from 2008. Staphylococcus aureus was isolated in 25.9% 
(21/81) and 12.8% (280/2186) of patients with and without ESKD, respectively (P=0.002). ESKD was associated with an in-
creased odds of death at 1 (44.9% versus 31.4%; adjusted odds ratio [aOR], 2.47, 95% CI, 1.85– 3.30;, P<0.001) and 3 years 
(63.9% versus 42.8%; aOR, 3.77; 95% CI, 2.79– 5.12; P<0.001).
CONCLUSIONS: IE is associated with a poor prognosis in patients with ESKD, especially in the longer term. Compared with 
patients without ESKD, patients with ESKD were twice as likely to die within 1 year, and 3 times as likely to die within 3 years 
of IE hospitalization.
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Infectious diseases are the second commonest cause of death after cardiovascular disease in pa-tients with end- stage kidney disease (ESKD) requir-
ing dialysis or with a kidney transplant.1,2 The incidence 
of infective endocarditis (IE) is ≈50- to 70- fold higher 
in those with ESKD compared with the general pop-
ulation, partly attributable to the use of arterio- venous 
grafts and indwelling catheters in patients undergoing 
dialysis, and long- term immunosuppression in renal 
transplant recipients.2– 4 The limited data available— 
mostly from small or single- center studies with short 
follow- up— suggest that the prognosis of IE in patients 
with ESKD is poor.2,3
With the increasing global burden of ESKD,5 con-
temporary population- based studies detailing the bur-
den and outcomes of IE in patients with ESKD would 
be invaluable for planning healthcare provision for this 
at- risk group. The aim of this nationwide data linkage 
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study was to investigate the clinical features, microbiol-
ogy and long- term outcomes of incident IE hospitaliza-




We conducted a retrospective, population- based co-
hort study linking national hospitalization, microbiol-
ogy, and mortality data sets in Scotland (Data S1).4
Study Population
Using International Classification of Diseases (ICD) 
coding and a 5- year look- back period (Tables S1 and 
S2), incident IE hospitalizations were identified from 
national inpatient records in those aged ≥20  years 
admitted to any Scottish hospital between January 1, 
1990 and December 31, 2014. To optimize specificity 
and sensitivity, we included only hospitalizations with 
a diagnostic code for IE appearing in the first 2 (of 6) 
positions of the national inpatient record. We extracted 
demographic data (age, sex, and deprivation status) 
and selected comorbidities (history of stroke, heart fail-
ure, myocardial infarction, cardiac device, and previ-
ous cardiac valvular surgery) (Data S1). Patients with 
ESKD were identified by searching linked inpatient re-
cords before incident IE hospitalization for relevant ICD 
codes (Table  S1) appearing in any of the 6 available 
diagnostic positions. Additionally, between January 1, 
2008 and December 31, 2014, incident IE hospitaliza-
tions were linked to blood culture data obtained from 
national microbiology records (Data S1).
Determination of Social Deprivation 
Status and Comorbidities
Social deprivation status was determined according 
to the Scottish Index of Multiple Deprivation (SIMD) 
(Data S1).6 SIMD is a geographical- based meas-
ure of deprivation. It is measured in quintiles, where 
the first and fifth quintiles are the most and least de-
prived, respectively. Every patient was assigned an 
SIMD quintile based on their individual SIMD rank at 
the time of incident IE hospitalization— determined by 
social factors related to residential address (zip code). 
Comorbidities (history of myocardial infarction, stroke, 
heart failure hospitalization, implanted cardiac device, 
and prior valvular heart surgery) were defined by identi-
fying relevant ICD codes attributed to inpatient records 
of hospitalizations and procedures during the 5 years 
preceding incident IE hospitalization (Data S1).4
Study Outcomes
Outcomes included stroke, heart failure, and subse-
quent valvular heart surgery at 1 and 3 years; and all- 
cause death at 30 days, 1 year, and 3 years.
Statistical Analysis
Clinical characteristics and outcomes were sum-
marized according to ESKD status. Groupwise com-
parisons were performed using Chi- square tests, as 
appropriate. Multivariable logistic regression (adjusted 
for age, sex, social deprivation status; history of stroke, 
heart failure and myocardial infarction) evaluated the 
association between ESKD and all- cause death at 
1 and 3  years in all patients hospitalized with IE. In 
a within- exposure analysis restricted to those with 
ESKD, multivariable logistic regression was used to 
determine factors associated with all- cause death 
at 1 and 3 years. Age, sex, and outcome data were 
complete for all IE hospitalizations. Data on social dep-
rivation status were missing in 0.6% of all IE hospitaliza-
tions; these records were excluded from our analysis. 
Statistical analysis was performed in R, Version 3.5.1 
(Vienna, Austria).
Ethical Considerations and Access to 
Study Data
The study was approved by the National Health Service 
Public Benefit and Privacy Panel (reference: 1516- 
0116). Patient consent was not sought as the analysis 
used fully anonymized data. Individual- level data are 
available via application to the National Health Service 
e- Data Research and Innovation Scotland team, which 
is part of Public Health Scotland. Access to original 
study data are restricted to approved members of the 
research team and will not be made publicly availa-
ble. However, these individual- level data are available 
via application to the National Health Service e- Data 
Research and Innovation Scotland team, which is part 
of Public Health Scotland. Source analysis code will 
be made available upon request to the corresponding 
author.
RESULTS
Of 7638 incident IE hospitalizations between January 
1, 1990 and December 31, 2014, 2.8% (216/7638) 
occurred in 210 patients with ESKD and 97.2% 
Nonstandard Abbreviations and Acronyms
ESKD end- stage kidney disease
IE infective endocarditis
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(7422/7638) occurred in 7303 patients without ESKD. 
Patients with ESKD were younger (58.9±14.3 versus 
65.2±17.3  years) and more likely to be men (56.9% 
versus 48.4%) than patients without ESKD (Table). 
Between January 1, 2008 and December 31, 2014, 
there were a total of 950 (41.9%) positive blood cul-
tures associated with 2267 incident IE hospitaliza-
tions (Table S3). During this period, the rate of positive 
blood cultures was higher in patients with ESKD than 
in patients without ESKD (58% [47/81] versus 41.3% 
[903/2186]) (P<0.004).
Staphylococcus spp. was the commonest 
genus identified in patients with (35.8%, 29/81) and 
without ESKD (17.1%, 374/2186) (P<0.001) (Table S3). 
Staphylococcus aureus was isolated in 25.9% 
(21/81) of patients with ESKD compared with 12.8% 
(280/2186) of patients without ESKD (P=0.002), whilst 
coagulase- negative Staphylococcus spp. were identi-
fied in 9.9% (8/81) of patients with ESKD versus 4.3% 
(94/2186) of patients without ESKD (P<0.03). In con-
trast, Streptococcus spp. was observed in 9.9% (8/81) 
of patients with ESKD and 15.1% (329/2186) of patients 
without (P=0.264).
Within 1 year of incident IE hospitalization, 13.9% 
(30/216) of patients with ESKD and 10.5% (783/7422) 
of patients without ESKD underwent valvular heart 
surgery (Table). At 3 years, these figures were 15.7% 
(34/216) and 12.7% (942/7422), respectively. All- cause 
mortality at 30  days was 18.5% (40/216) in patients 
with ESKD, compared with 14.0% (1041/7422) in pa-
tients without ESKD (Table). Within 1 year of incident 
IE hospitalization, 44.9% (97/216) of patients with 
ESKD and 31.4% (2329/7422) of patients without 
ESKD had died (adjusted odds ratio [aOR], 2.47; 95% 
CI, 1.85– 3.30; P<0.001) (Figure [A]). At 3 years, these 
figures were 63.9% (138/216) and 42.8% (3179/7422), 
respectively (aOR, 3.77; 95% CI, 2.79– 5.12; P<0.001) 
(Figure B).
In patients with ESKD, older age was associated 
with a significantly increased odds of death at both 1 
(aOR, 1.34 per 10- year increase in age; 95% CI, 1.09– 
1.67; P<0.001) and 3  years (aOR, 1.44 per 10- year 
increase in age; 95% CI, 1.16– 1.81; P=0.001) follow-
ing incident IE hospitalization. However, lower levels 
of social deprivation were associated with a reduced 
odds of death at 3 years only (aOR, 0.34 for least ver-
sus most deprived SIMD quintile; 95% CI, 0.12– 0.92; 
P=0.037) (Table S4).
DISCUSSION
To date, this is one of the largest nationwide data link-
age studies to compare the clinical characteristics, 
microbiology, and long- term outcomes of IE in pa-
tients with and without ESKD. One fifth of patients 
with ESKD died within 30  days of their incident IE 
hospitalization, half died within 1 year, and two thirds 
within 3 years. Compared with those without ESKD, 
patients with ESKD were twice as likely to die within 
1 year of IE hospitalization and >3 times as likely to 
die within 3 years. In patients with ESKD, older age 
was independently associated with a poorer progno-
sis at both 1 and 3 years, whilst the lowest level of 
deprivation was associated with better outcomes at 
3 years only.
The few studies that have defined the microbiology of 
IE in patients with ESKD report Staphylococcus aureus 
infection rates of ≈50% to 80%7,8— substantially higher 
Table. Clinical Characteristics and Outcomes of Patients 
With and Without ESKD Hospitalized With Incident Infective 
Endocarditis in Scotland Between 1990 and 2014
ESKD No ESKD
No. of hospitalizations, n (%) 216 (2.8) 7422 (97.2)
Mean age, y (SD) 58.9 (14.3) 65.2 (17.3)
Sex, n (%)
Men 123 (56.9) 3595 (48.4)
Women 93 (43.1) 3827 (51.6)
SIMD quintile, n (%)*
1 (most deprived) 49 (22.7) 1878 (25.3)
2 56 (25.9) 1687 (22.7)
3 51 (23.6) 1386 (18.7)
4 27 (12.5) 1273 (17.2)
5 (least deprived) 31 (14.4) 1156 (15.6)
Previous medical conditions, n (%)
Myocardial infarction 14 (6.5) 339 (4.6)
Stroke 16 (7.4) 400 (5.4)
Heart failure 24 (11.1) 1141 (15.4)
Cardiac device 9 (4.2) 199 (2.7)
Prior cardiac valve surgery 18 (8.3) 679 (9.1)
All- cause death, n (%)
30 d 40 (18.5) 1041 (14.0)
1 y 97 (44.9) 2329 (31.4)
3 y 138 (63.9) 3179 (42.8)
Other outcomes at 1 y, n (%)
Stroke 13 (6.0) 310 (4.2)
Heart failure hospitalization 16 (7.4) 914 (12.3)
Subsequent cardiac valve 
surgery
30 (13.9) 783 (10.5)
Other outcomes at 3 y, n (%)
Stroke 14 (6.5) 443 (6.0)
Heart failure hospitalization 21 (9.7) 1272 (17.1)
Subsequent cardiac valve 
surgery
34 (15.7) 942 (12.7)
ESKD indicates end- stage kidney disease; and SIMD, Scottish Index of 
Multiple Deprivation.
*SIMD quintile was available for 99.1% (214/216) and 99.4% (7,380/7,422) 
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Figure. Forest plot showing adjusted odds ratios and 95% CIs from multivariable logistic regression models evaluating the 
association between end- stage kidney disease and all- cause death at 1 (A) and 3 years (B).
Number of observations (each model): 7594. Please note x- axes for (A and B) have different scales. ESKD indicates end- stage kidney 
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than in the current study. However, these types of co-
hort study often rely on cases of IE being identified by 
clinicians, increasing the risk of selection bias and thus, 
the proportion of patients with positive microbiology. In 
contrast, our study— which used individual patient- level 
blood culture data— was free from selection bias as all 
IE hospitalizations were identified from routine diagnos-
tic coding, the accuracy of which was recently reported 
as ≈94% for cardiovascular diagnoses.9
Whilst short- term outcomes of IE are similar be-
tween those with and without ESKD, patients with 
ESKD do worse in the longer term. Our data are 
consistent with a contemporary Danish study3 and 
compare favorably with an American study in pa-
tients with ESKD performed ≈20 years ago,10 which 
described 1- and 3- year mortality rates of 61.6% 
and 81.7%, respectively. In addition, the in- hospital 
mortality described in a recently published single- 
center study from Taiwan was approximately dou-
ble the figure we report at 30  days, despite similar 
Staphylococcus aureus infection rates.11 Bhatia and 
colleagues12 previously demonstrated a comparable 
increased risk of death in patients with and without 
ESKD. Although well- powered, their analysis was re-
stricted to in- hospital death only. In this regard, the 
long- term outcomes we report are more relevant in 
the contemporary era, given ≈80% of patients with 
ESKD survive the initial IE hospitalization.
There are some limitations to consider. Our anal-
ysis was under- powered to stratify outcomes by 
renal replacement therapy (hemodialysis, peritoneal 
dialysis or renal transplant) or microbiological etiol-
ogy, or to include these variables in the multivariable 
regression analyses. As we used routine adminis-
trative ICD codes to identify IE hospitalizations, our 
study was free from selection bias but subject to 
case ascertainment bias. To limit the impact of this, 
the study cohort was restricted to hospitalizations 
with a diagnostic code for IE in the first 2 (of 6) 
positions.
Overall, this comprehensive nationwide analysis 
over a 25- year period highlights the poor prognosis as-
sociated with IE in patients with ESKD compared with 
patients without ESKD, especially in the longer term. 
Our results underscore the importance of a multidis-
ciplinary approach to the clinical management of this 
complex and vulnerable patient group.
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Scottish Morbidity Record 01 (SMR01) 
The Scottish Morbidity Record 01 (SMR01) is an episode-based hospitalization record, indexed 
by community health index (CHI) number, relating to all inpatient and day case hospitalizations 
from non-obstetric and non-psychiatric specialties.13 A record is generated when a patient 
completes an episode of inpatient or day case care. Up to six diagnoses are recorded using the 
International Classification of Diseases (ICD) classification, whilst interventions or procedures 
are recorded using the OPCS-4 classification. SMR01 data are considered amongst the best 
routinely-collected healthcare data worldwide in terms of granularity, population coverage and 
linkage capabilities. Across all SMR01 records, estimated completion and accuracy rates are 
99% and 89%, respectively.14 For SMR01 records relating to cardiovascular diagnoses, the 
accuracy rate is 94.2%.9 
National Records of Scotland (NRS) Death Records 
The NRS register is indexed by CHI number and records all deaths in Scotland, with ~55,000 
deaths registered annually. Available data from individual patients include demographics, date 
of death, and primary and secondary causes of death.15 These data were linked to patients 
identified as having a record of an incident IE hospitalization during the study period. Of note, 
it is a statutory requirement that any death occurring in Scotland, or out-with Scotland but 
within the United Kingdom, is registered on the NRS death register within 8 days of death. 
Although patients who emigrate to other countries will be lost to follow-up, the Scottish 
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Electronic Communication of Surveillance in Scotland (ECOSS) 
The Scottish microbiology surveillance registry or ‘Electronic Communication of Surveillance 
in Scotland’ (ECOSS), as it is termed by NHS National Services Scotland, was used to identify 
positive blood culture results from microbiology laboratories within NHS Scotland health 
boards pertaining to incident IE hospitalizations in SMR01 between 01/01/2008 and 
12/31/2014. Causative organisms were defined as those identified ≤90 days on either side of 
the incident IE hospitalization date. Polymicrobial status was defined when >1 causative 
organism was identified on the same culture date. If >1 causative organism was identified on 
different dates ≤90 days on either side of the incident IE hospitalization date, then the organism 
identified closest to the incident IE hospitalization date was assigned as the causative organism. 
Although data were first recorded in ECOSS from 2007, near-complete data are available from 
2008 and so ECOSS records were linked to SMR01 in the present study from this year 
onwards.17,18 ECOSS is maintained by NHS National Services Scotland on behalf of Health 
Protection Scotland. NHS National Services Scotland monitors the completeness and accuracy 
of ECOSS data through its ‘Data Monitoring and Support Service’.17 Further, NHS National 
Services Scotland routinely informs data users of any problems affecting the accuracy of these 
data. More information on ECOSS is available from https://www.hps.scot.nhs.uk/data/. 
Identification of study participants 
Incident hospitalizations with infective endocarditis (IE), end-stage kidney disease (ESKD) 
status and comorbidities were defined from SMR01 in patients aged ≥20 years admitted to any 
Scottish hospital between 01/01/1990 and 12/31/2014 using International Classification 
of Diseases (ICD) codes (Table S1). To optimize specificity and sensitivity, we included 
only hospitalizations with a diagnostic code for IE appearing in the first 2 (of 6) 
positions of the SMR01 record. We extracted demographic data (age, sex and deprivation status 
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infarction, cardiac device and previous cardiac valvular surgery) from SMR01 using records of 
hospitalizations and procedures during the 5 years preceding hospital admission (a 5-year ‘look-
back’ period). Patients with ESKD were identified by searching linked inpatient records prior 
to hospitalization with IE for relevant ICD codes (Table S1) appearing in any of the 6 
available diagnostic positions. 
Definition of deprivation status: the Scottish Index of Multiple Deprivation (SIMD) 
The Scottish Index of Multiple Deprivation (SIMD) is a geographical-based measure of 
deprivation. SIMD identifies small geographical regions (where each region is determined by 
zip code and corresponds to ~750 residents) of material deprivation based on information 
derived from seven domains (income; employment; health; education, skills and training; 
geographic access to services; crime; and housing).6 Each domain is weighted according to its 
relative importance and provides a score which is then summed with the other domains. The 
total score for each geographical region enables the areas to be ranked. SIMD scores and ranks 
(quintiles/deciles) have been used extensively in published epidemiological research from 
Scotland.6 In this study, all patients were assigned a SIMD quintile based on their individual 
SIMD rank at the time of incident IE hospitalization. 
Description of look-back period 
Table S2 illustrates the look-back period for the years 2000-2010 in three exemplar 
patients (patients A, B and C). The total incident count for each year is shown in the final 
column. Where a patient is hospitalized with an episode of IE, a ‘1’ appears in the 
‘Admission’ column. If no IE event has occurred in the 5-years prior (light grey shading), then 
the event is considered an incident event and a ‘1’ will also appear in the ‘Incident’ column 
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Table S1. List of International Classification of Diseases codes employed in study to 
identify incident cases of infective endocarditis, patients with end-stage kidney disease and 
their comorbidities. Abbreviations: ICD – International Classification of Diseases. 
Relevant ICD codes 
Infective endocarditis 
ICD-9 421.1, 424.91, 424.90, 424.99 
ICD-10 I33, I38, I39 
End-stage kidney disease 
ICD-9 V45.1, V45.11, V56.0 - V56.2, V56.8 
ICD-10 Z49.0 - Z49.2, Z94.0, Z99.2 
Myocardial infarction 
ICD-9 413 
ICD-10 I21, I22 
Stroke 





Cardiac valvular surgery 
OPCS-4 K04 - K12, K14, K17 - K34 
Cardiac devices 
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Table S2. Schematic of the five-year look-back period employed in this study in 3 fictional 
patients (A, B and C). 
Year 
Patient A Patient B Patient C Total 
incident 
events Admission Incident Admission Incident Admission Incident 
2000 0 0 0 0 0 0 0 
2001 0 0 1 1 0 0 1 
2002 0 0 0 0 0 0 0 
2003 0 0 0 0 0 0 0 
2004 0 0 0 0 0 0 0 
2005 1 1 0 0 1 1 2 
2006 1 0 0 0 0 0 0 
2007 0 0 0 0 1 0 0 
2008 0 0 1 1 0 0 1 
2009 1 0 0 0 0 0 0 
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Table S3. Clinical characteristics of patients with and without end-stage kidney disease 
hospitalized with infective endocarditis in Scotland between 2008 and 2014, and for whom 
microbiology data were available. *counts of ≤5 are redacted in line with regulatory 
approvals to protect patient confidentiality. Abbreviations: ESKD – end-stage kidney disease; 
SIMD – Scottish Index of Multiple Deprivation. 
ESKD No ESKD 
Number of hospitalizations, n (%) 81 (3.6) 2,186 (96.4) 
Age, years (SD) 59.7 (13.1) 66.8 (17.8) 
Sex, n (%) 
Men 52 (64.2) 1,138 (52.1) 
Women 29 (35.8) 1,048 (47.9) 
SIMD quintile, n (%) 
1 (most deprived) 20 (24.7) 507 (23.2) 
2 23 (28.4) 497 (22.7) 
3 22 (27.2) 435 (19.9) 
4 7 (8.6) 379 (17.3) 
5 (least deprived) 8 (9.9) 357 (16.3) 
Previous medical conditions, n (%) 
Myocardial infarction 6 (7.4) 107 (4.9) 
Stroke 7 (8.6) 105 (4.8) 
Heart failure hospitalization NA* 254 (11.6) 
Cardiac device NA* 53 (2.4) 
Prior cardiac valve surgery NA* 167 (7.6) 
Microbiology, n (%) 
Staphylococcus aureus 21 (25.9) 280 (12.8) 
Coagulase-negative Staphylococcus spp. 8 (9.9) 94 (4.3) 
Streptococcus spp. 8 (9.9) 329 (15.1) 
Other (polymicrobial/Enterococcus spp.) 10 (12.3) 200 (9.1) 
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Table S4. Odds ratios and 95% confidence intervals from logistic regression model for outcome of death at 1 and 3 years in patients with end-stage 
kidney disease (ESKD) only. The model adjusted for age, sex, deprivation status and history of stroke, heart failure hospitalization and 
myocardial infarction. Abbreviations: CI – confidence interval; SIMD – Scottish Index of Multiple Deprivation. 
















Age, per 10 year increase 1.34 1.09 1.67 0.006 1.44 1.16 1.81 0.001 
Female sex 0.77 0.43 1.38 0.379 1.03 0.56 1.90 0.928 
SIMD quintile 
(1 = most deprived; 5 = least deprived) 
2 (vs. quintile 1) 0.79 0.35 1.76 0.565 1.07 0.45 2.55 0.880 
3 (vs. quintile 1) 0.65 0.28 1.48 0.308 0.51 0.21 1.19 0.124 
4 (vs. quintile 1) 1.51 0.56 4.18 0.418 1.52 0.50 5.01 0.470 
5 (vs. quintile 1) 0.38 0.13 1.01 0.059 0.34 0.12 0.92 0.037 
Comorbidities 
Stroke 0.71 0.21 2.13 0.552 0.75 0.24 2.38 0.612 
Heart failure hospitalisation 0.77 0.29 1.96 0.593 2.01 0.71 6.68 0.213 
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